Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010-Reference-Cited by-同舟云学术

Blood use in hematologic malignancies: a nationwide overview in Sweden between 2000 and 2010

Published:2017-12-17 Issue:2 Volume:58 Page:390-401
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Zhao Jingcheng¹,Rydén Jenny²,Wikman Agneta³⁴,Norda Rut⁵,Stanworth Simon J.⁶,Hjalgrim Henrik⁷⁸,Edgren Gustaf¹²

Affiliation:

1. Department of Medical Epidemiology and Biostatistics; Karolinska University Hospital; Stockholm Sweden

2. Department of Hematology; Karolinska University Hospital; Stockholm Sweden

3. Department of Clinical Immunology and Transfusion Medicine; Karolinska University Hospital; Stockholm Sweden

4. Department of Laboratory Medicine; Karolinska Institutet; Stockholm Sweden

5. Department of Immunology, Genetics and Pathology; Uppsala University; Uppsala Sweden

6. Transfusion Medicine, NHS Blood and Transplant, and the Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Radcliffe Department of Medicine; University of Oxford, and Oxford BRC Hematology Theme; Oxford UK

7. Department of Epidemiology Research; Statens Serum Institut

8. Department of Hematology; Copenhagen University Hospital; Copenhagen Denmark

Funder

Swedish Research Council

Swedish Heart-Lung Foundation

Swedish Society for Medical Research

Strategic Research Program in Epidemiology at Karolinska Institutet

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14440/fullpdf

Reference16 articles.

1. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation;Estcourt;Cochrane Database Syst Rev,2015

2. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion;Carson;Cochrane Database Syst Rev,2016

3. Red blood cell transfusion triggers in acute leukemia: a randomized pilot study;DeZern;Transfusion,2016

4. Tay J Allan DS Coyle D 2016

5. Where do all the red blood cells (RBCs) go? Results of a survey of RBC use in England and North Wales in 2014;Tinegate;Transfusion,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying principles of patient blood management during COVID-19 pandemic: a literature review;Annals of Blood;2023-06

2. Defining Current Patterns of Blood Product Use during Intensive Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients;Transfusion Medicine and Hemotherapy;2023

3. Blood Use in Haematological Malignancies in Calabar;Nigerian Journal of Medicine;2022

4. Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study;Vox Sanguinis;2020-11-18

5. The Swedish Scandinavian donations and transfusions database (SCANDAT3‐S) – 50 years of donor and recipient follow‐up;Transfusion;2020-08-21